ADA and tuberculosis: When the levels were tested during anti-TB treatment and compared with baseline levels, a significant decrease was seen in the levels of all three biomarkers at 2 [Ferritin (p = 0.001), CRP (p < 0.001), and ADA (p = 0.039), and 6 months (p < 0.001), CRP (p < 0.001), ADA p < 0.004) of anti-TB treatment.